$97 million to help Children’s and Emory target advances in childhood diseases.
The drug abatacept was shown to significantly reduce the risk of acute graft-versus-host disease (GVHD) among children and adults undergoing unrelated donor blood and marrow transplant for hematologic cancer during a seven-year, multisite trial.
College football fans fight childhood cancer by pledging donations throughout the season
Musholt Named New Foundation President Children’s appoints Janine Musholt as the new President of the Children’s Foundation Tuesday, Oct. 27, 2020 Children’s appoints Janine Musholt as the new...
Study Shows Steroids Reduce Opioid Use Patients receiving steroids after scoliosis surgery used pain medicine 40% less often Wednesday, Oct. 21, 2020 Patients receiving steroids after scoliosis...
Construction has begun on largest healthcare project in Georgia's history with $200 million donation from The Arthur M. Blank Family Foundation
$18.2M to Continue COVID-19 Diagnostic Testing A total of $54 million has been awarded to Atlanta institutions for RADx projects Monday, Oct. 05, 2020 A total of $54 million has been awarded to...
Expert Urges Start of COVID-19 Vaccine Trials in Kids Dr. Anderson says COVID-19 vaccine for kids could facilitate return to school Monday, Sept. 21, 2020 Dr. Anderson says COVID-19 vaccine for kids...
The trial will utilize the national Pediatric Emergency Care Applied Research Network (PECARN)
A Children’s Healthcare of Atlanta patient has become the youngest patient to date to receive experimental convalescent plasma transfusions to treat the novel coronavirus.